[HTML] sciencedirect.com

[HTML][HTML] CEFTO-CURE study: CEFTObiprole Clinical Use in Real-lifE–a multi-centre experience in Italy

I Gentile, AR Buonomo, S Corcione, L Paradiso… - International Journal of …, 2023 - Elsevier
Background Ceftobiprole is approved in Europe for treatment of community-acquired
pneumonia and non-ventilator-associated hospital-acquired pneumonia (HAP) in adults …
被引用次数：12 相关文章

CEFTO-CURE study: CEFTObiprole Clinical Use in Real-lifE–a multi-centre experience in Italy

I Gentile, AR Buonomo, S Corcione… - INTERNATIONAL …, 2023 - iris.unicampania.it
Background: Ceftobiprole is approved in Europe for treatment of community-acquired
pneumonia and non-ventilator-associated hospital-acquired pneumonia (HAP) in adults …

CEFTO-CURE study: CEFTObiprole clinical use in Real-lifE-a multi-centre experience in Italy.

I Gentile, AR Buonomo, S Corcione, L Paradiso… - 2023 - cabidigitallibrary.org
Background: Ceftobiprole is approved in Europe for treatment of community-acquired
pneumonia and non-ventilator-associated hospital-acquired pneumonia (HAP) in adults …

CEFTO-CURE study: CEFTObiprole Clinical Use in Real-lifE-a multi-centre experience in Italy

I Gentile, AR Buonomo, S Corcione… - International …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Ceftobiprole is approved in Europe for treatment of community-acquired
pneumonia and non-ventilator-associated hospital-acquired pneumonia (HAP) in adults …

CEFTO-CURE Study: CEFTObiprole Clinical Use in Real-lifE-a multi-centre experience in Italy.

I Gentile, AR Buonomo, S Corcione… - International Journal …, 2023 - europepmc.org
Ceftobiprole is approved in Europe for community-acquired pneumonia (CAP) and non-
ventilator associated hospital-acquired pneumonia (HAP) in adults. Real-life data are …